Trials / Completed
CompletedNCT01211366
Use of Cell Salvage Post-operatively in Infants to Decrease Use of Allogeneic Blood Product Transfusions
Post-operative Infusion of Intra-operative Cell Salvage Reduces Allogeneic Blood Product Transfusions and Volume Resuscitation in Pediatric Cardiac Surgery and Improves Clinical Outcomes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Transfusion of washed intra-operative cell salvage post-operatively in the PCICU can be performed safely without increased risk of bleeding or release of inflammatory mediators. This will reduce the need for allogeneic blood products as well as crystalloid and colloid infusions and thus decrease the length of ventilation and intensive care duration for these infants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cell Saver RBCs | Use of cell saver RBCs to decrease the infusion of allogeneic PRBCs, crystalloid, and colloid in post-operative infants following CPB as needed for hemodynamic instability |
| OTHER | Conventional volume infusion | Infusion of allogeneic PRBCs, crystalloid, and colloid as needed for hemodynamic instability |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2010-09-29
- Last updated
- 2012-02-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01211366. Inclusion in this directory is not an endorsement.